• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

SHPG:US

256.3000 USD 1.8700 0.72%

As of 16:00:00 ET on 09/22/2014.

Snapshot for Shire PLC (SHPG)

Open: 257.5300 Day's Range: 255.3400 - 259.9900 Volume: 846,813
Previous Close: 258.1700 52wk Range: 113.5900 - 262.3200 1-Yr Rtn: +108.20%

Stock Chart for SHPG

No chart data available.
  • SHPG:US 256.4700
  • 1D
  • 1M
  • 1Y
258.1700
Interactive SHPG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SHPG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 26.1632
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 9.7920
Est. PEG Ratio 2.0956
Market Cap (M USD) 50,340.78
Shares Outstanding (M) 196.52
30 Day Average Volume 979,521
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.09%
Cash Dividend (USD) 0.1149
Dividend Ex-Date 09/03/2014
5 Year Dividend Growth 15.94%
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SHPG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SHPG

Shire PLC markets, licenses and develops prescription medicines. The Group focuses its operations on attention deficit and hyperactivity disorders, human genetic therapies, gastrointestinal, and renal diseases.

Flemming OrnskovChief Executive OfficerJames BowlingInterim CFO/Senior VP/Controller
Tatjana MaySecretary/General CounselJeff PoultonHead:Investor Relations
More Company Profile & Key Executives for SHPG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil